Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are 2-week trials sufficient to indicate efficacy?

S A Montgomery1

  • 1Department of Psychiatry, St Mary's Hospital Medical School, London, UK.

Psychopharmacology Bulletin
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intermittent At-Home Suctioning of Esophageal Content for Prevention of Recurrent Aspiration Pneumonia in 4 Dogs with Megaesophagus.

Journal of veterinary internal medicine·2016
Same author

Identification of candidate genes for chicken early- and late-feathering.

Poultry science·2016
Same author

Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Prophylaxis in recurrent unipolar depression: a new indication for treatment studies.

Journal of psychopharmacology (Oxford, England)·2011
Same author

Clinical measures of rapid onset of action.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder.

International journal of clinical practice·2008

Antidepressant efficacy can be demonstrated in 2-week studies by analyzing the time to response, not just full response. This method better detects early improvements compared to traditional trial designs.

Area of Science:

  • Psychiatry and Clinical Pharmacology
  • Neuroscience
  • Medical Research Methodology

Background:

  • The perceived delay in antidepressant action stems from conflating full response with initial symptom improvement.
  • Conventional clinical trial designs often lack the sensitivity to detect early differences between antidepressant drugs and placebo.

Purpose of the Study:

  • To address the limitations of current trial designs in detecting early antidepressant effects.
  • To propose a more sensitive methodology for demonstrating antidepressant efficacy.

Main Methods:

  • Critically evaluating the distinction between "full response" and "appearance of improvement" in antidepressant trials.
  • Analyzing "time to response" as a more sensitive metric for detecting early drug-placebo differences.

Related Experiment Videos

  • Proposing the use of 2-week study durations to assess antidepressant efficacy.

    • Main Results:

    • "Time to response" analysis is more sensitive than traditional measures for identifying early antidepressant effects.
    • Conventional trial designs are inadequate for detecting subtle, early improvements.
    • Early separation between drug and placebo effects can be identified within a shorter timeframe.

    Conclusions:

    • The concept of delayed antidepressant action is likely a misinterpretation of clinical trial data.
    • Analyzing "time to response" in 2-week studies offers a valid and sensitive method for demonstrating antidepressant efficacy.
    • Future antidepressant research should consider shorter study designs focused on early response metrics.